跳到主要內容

Burns James William 的 Form 4 申報

Agios Pharmaceuticals, Inc.(AGIO),2024/11/12 申報

申報編號
0001439222-24-000140
申報時間
2024/11/12
交易日
2024/11/7
申報延遲
5 天
10b5-1 計畫
有勾選

這份申報列了 2 筆非衍生性交易。公開市場賣出合計 $113.6 萬。交易後 5 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Burns James WilliamCIK 0001900772高階主管(法務長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2024/11/7Common stockS賣出處分−13,411$52.00F2−$697,37224,041直接
2024/11/7Common stockS賣出處分−8,341$52.56F4−$438,402.9615,700直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $51.33 to $52.32. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $52.33 to $52.88. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)